Research progress in endoscopic retrograde cholangiopancreatography-mediated photodynamic therapy for cholangiocarcinoma

Kunpeng Wang, Li Xiong, Zijian Zhang, Kai Liu, Yunpeng Huang, Xin Yang, Qinglong Li, Wei Chen, Heng Zou, Yu Wen*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Th e malignant degree of cholangiocarcinoma is high, and the early diagnosis is diffi cult. Th e vast majority of patients are unresectable when they are diagnosed. Th e patients have low quality of life and short survival cycle. Traditional radiotherapy and chemotherapy have poor effi cacy and lead to side effects, and thus lack effective control measures for cholangiocarcinoma. Endoscopic retrograde cholangiopancreatography (ERCP) is an important method for diagnosing and treating biliary tract diseases. Photodynamic therapy (PDT) is a new local treatment for cholangiocarcinoma. In recent years, ERCP-mediated PDT treatment of cholangiocarcinoma has gradually emerged. ERCPmediated PDT can effectively relieve the symptoms of patients with cholangiocarcinoma, improve the patients' quality of life, prolong the survival cycle, and is expected to become a new treatment for cholangiocarcinoma.

Original languageEnglish
Pages (from-to)1275-1280
Number of pages6
JournalJournal of Central South University (Medical Sciences)
Issue number11
Publication statusPublished - Nov 2019
Externally publishedYes


  • Cholangiocarcinoma
  • Endoscopic retrograde cholangiopancreatography
  • Photodynamic therapy


Dive into the research topics of 'Research progress in endoscopic retrograde cholangiopancreatography-mediated photodynamic therapy for cholangiocarcinoma'. Together they form a unique fingerprint.

Cite this